A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan

Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison

(2015) Salvatore Brugaletta et al.   JACC-Cardiovascular Interventions

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds

(2015) Serban Puricel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

(2015) Patrick W Serruys et al.   LANCET

An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition)

(2015) John A. Ormiston et al.   EuroIntervention

Implantation of a novolimus-eluting bioresorbable scaffold with a strut thickness of 100 µm showing evidence of self-correction

(2015) Jens Wiebe et al.   EuroIntervention

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

(2015) Davide Capodanno et al.   EuroIntervention

Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective

(2015) Corrado Tamburino et al.   EuroIntervention

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

(2014) Patrick W. Serruys et al.   EuroIntervention

Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary Revascularization

(2013) Issam D. Moussa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

(2012) Takeshi Kimura et al.   CIRCULATION

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

(2012) Tullio Palmerini et al.   LANCET

Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent

(2011) Yoshinobu Onuma et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Very Late Stent Thrombosis and Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

(2011) Takeshi Kimura et al.   CIRCULATION

Serial Analysis of the Malapposed and Uncovered Struts of the New Generation of Everolimus-Eluting Bioresorbable Scaffold With Optical Coherence Tomography

(2011) Josep Gomez-Lara et al.   JACC-Cardiovascular Interventions

Angiographic Surrogate End Points in Drug-Eluting Stent Trials

(2008) Stuart J. Pocock et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

(2008) John A Ormiston et al.   LANCET